| 药物洗脱支架植入后再狭窄的研究进展 |
| |
| 引用本文： | 徐巍李悦.药物洗脱支架植入后再狭窄的研究进展[J].现代生物医学进展,2012,12(26):5195-5197. |
| |
| 作者姓名： | 徐巍李悦 |
| |
| 作者单位： | 哈尔滨医科大学 黑龙江哈尔滨150081 |
| |
| 摘 要： | 随着药物洗脱支架(Drug Eluting Stent,DES)的出现,再狭窄的问题得到进一步的有效控制.然而,药物洗脱支架也存在较低的再狭窄率,由于应用药物洗脱支架治疗人数非常多,这一比率就不容忽视.本文将阐述DES支架内再狭窄发生的病理生理学机制、临床表现、形态学特征以及处理策略.
|
| 关 键 词： | 药物洗脱支架 支架内再狭窄 内膜增生 |
Progress in In-Stent Restenosis of Drug-Eluting Stent |
| |
| XU Wei,LI Yue.Progress in In-Stent Restenosis of Drug-Eluting Stent[J].Progress in Modern Biomedicine,2012,12(26):5195-5197. |
| |
| Authors: | XU Wei LI Yue |
| |
| Institution: | △(Harbin medical university,Harbin,Heilongjiang,150001,China) |
| |
| Abstract: | With the emergence of drug-eluting stents(DES),restenosis have further effective controled.However,a low rate of in-stent restenosis(ISR) after DES still exists,and its prevalence is not negligible because the population treated with DES is large.We sought to provide a concise,comprehensive overview of the pathophysiologic mechanisms,clinical presentation,morphologic patterns,and management options of DES ISR. |
| |
| Keywords: | Drug-Eluting Stent In-Stent Restenosis Intimal hyperplasia |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《现代生物医学进展》浏览原始摘要信息 |
| 点击此处可从《现代生物医学进展》下载免费的PDF全文 |
|
